General Information of the Compound
| Compound ID |
CP0918739
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)-5-methoxy-2,6-dimethylpyrimidine-4-carboxamide hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H26Cl3N5O2
|
||||||||||||||||||
| Molecular Weight |
474.82
|
||||||||||||||||||
| Canonical SMILES |
COc1c(C)nc(C)nc1C(=O)NCCN1CCN(c2cccc(Cl)c2Cl)CC1.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H25Cl2N5O2.ClH/c1-13-19(29-3)18(25-14(2)24-13)20(28)23-7-8-26-9-11-27(12-10-26)16-6-4-5-15(21)17(16)22;/h4-6H,7-12H2,1-3H3,(H,23,28);1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
LSXRPPLOEWTOFU-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT00871, Sodium-dependent serotonin transporter